Galmed shares surged after announcing a new brain-penetrating formulation for treating Parkinson's.

Critics question India's new drug approval rules, citing fairness concerns.

New Zealand funds new CLL treatments starting May 2026.

SS Innovations unveils drone-enabled remote robotic surgery system for combat zones.

FDA rejects Replimune's melanoma drug RP1 for lack of effectiveness.

EU approves Dupixent for young children with chronic urticaria.

Chinese man regains movement after stroke using non-invasive mind-controlled system.

Merck extends Keytruda exclusivity with aggressive patents, costing patients over $200,000 annually.

Veterinary drug fenbendazole gains renewed interest amid consumer demand and early studies.

Zimbabwe recalls Azithromycin batch due to quality defects.